E
Verrica Pharmaceuticals Inc. VRCA
$5.23 -$0.12-2.24% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 204.00K -9.74M -16.20M -22.86M -17.19M
Total Depreciation and Amortization 199.00K 208.00K 253.00K 342.00K 334.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1.16M 1.44M 3.98M 2.94M 2.89M
Change in Net Operating Assets -11.61M -4.59M -4.09M 11.02M -2.39M
Cash from Operations -10.04M -12.68M -16.06M -8.56M -16.36M
Capital Expenditure -- -- 0.00 -16.00K -11.00K
Sale of Property, Plant, and Equipment -- -- 8.00K -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- 8.00K -16.00K -11.00K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -4.16M -4.06M -374.00K -217.00K -177.00K
Issuance of Common Stock -- -- 39.64M 0.00 150.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 162.00K -180.00K -613.00K
Cash from Financing -4.16M -4.06M 39.43M -397.00K -640.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -14.20M -16.73M 23.37M -8.97M -17.01M